

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.77913743 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.77913743 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.22148886 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.63735795 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 5.72417790 |
| 6 | negative thymic T cell selection (GO:0045060) | 5.58441091 |
| 7 | negative T cell selection (GO:0043383) | 5.49847935 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.15002735 |
| 9 | negative regulation of cell killing (GO:0031342) | 5.15002735 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.00019893 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.95494444 |
| 12 | T cell migration (GO:0072678) | 4.90674595 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.81450213 |
| 14 | positive thymic T cell selection (GO:0045059) | 4.73863606 |
| 15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.63449619 |
| 16 | thymic T cell selection (GO:0045061) | 4.57446254 |
| 17 | response to type I interferon (GO:0034340) | 4.50200204 |
| 18 | cellular response to type I interferon (GO:0071357) | 4.44466680 |
| 19 | type I interferon signaling pathway (GO:0060337) | 4.44466680 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 4.37845133 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 4.37845133 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.37845133 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.37845133 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.37845133 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.37845133 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.36529677 |
| 27 | response to interleukin-15 (GO:0070672) | 4.36199600 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.34741724 |
| 29 | detection of other organism (GO:0098543) | 4.34201219 |
| 30 | detection of bacterium (GO:0016045) | 4.32152434 |
| 31 | T cell selection (GO:0045058) | 4.31249551 |
| 32 | regulation of T cell tolerance induction (GO:0002664) | 4.20101749 |
| 33 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.14935322 |
| 34 | positive regulation of humoral immune response (GO:0002922) | 4.06895226 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.01986344 |
| 36 | interferon-gamma production (GO:0032609) | 4.01024270 |
| 37 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.00245374 |
| 38 | cellular response to interleukin-15 (GO:0071350) | 3.98140972 |
| 39 | positive T cell selection (GO:0043368) | 3.97992738 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.96968471 |
| 41 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.94415256 |
| 42 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.86351331 |
| 43 | macrophage activation involved in immune response (GO:0002281) | 3.82954071 |
| 44 | activated T cell proliferation (GO:0050798) | 3.80735447 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.72351163 |
| 46 | regulation of RIG-I signaling pathway (GO:0039535) | 3.65183527 |
| 47 | myeloid dendritic cell activation (GO:0001773) | 3.63900200 |
| 48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.61533883 |
| 49 | cellular extravasation (GO:0045123) | 3.61206335 |
| 50 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.61142484 |
| 51 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.59023176 |
| 52 | positive regulation of interleukin-2 production (GO:0032743) | 3.58448708 |
| 53 | myeloid dendritic cell differentiation (GO:0043011) | 3.57764465 |
| 54 | neutrophil activation involved in immune response (GO:0002283) | 3.56387363 |
| 55 | positive regulation of interferon-alpha production (GO:0032727) | 3.52601613 |
| 56 | regulation of B cell differentiation (GO:0045577) | 3.47354291 |
| 57 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.45476446 |
| 58 | detection of external biotic stimulus (GO:0098581) | 3.45418896 |
| 59 | positive regulation of B cell differentiation (GO:0045579) | 3.44029923 |
| 60 | regulation of regulatory T cell differentiation (GO:0045589) | 3.42898598 |
| 61 | response to peptidoglycan (GO:0032494) | 3.42760565 |
| 62 | positive regulation of antigen processing and presentation (GO:0002579) | 3.40887510 |
| 63 | * regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.39680031 |
| 64 | leukocyte aggregation (GO:0070486) | 3.38797469 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 3.35552275 |
| 66 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.34767695 |
| 67 | positive regulation of isotype switching (GO:0045830) | 3.34382266 |
| 68 | T cell receptor signaling pathway (GO:0050852) | 3.33038305 |
| 69 | positive regulation of granulocyte differentiation (GO:0030854) | 3.29120754 |
| 70 | tolerance induction (GO:0002507) | 3.28881094 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.27317174 |
| 72 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.26813733 |
| 73 | T cell costimulation (GO:0031295) | 3.26308801 |
| 74 | cellular response to interferon-beta (GO:0035458) | 3.25900614 |
| 75 | lymphocyte migration (GO:0072676) | 3.24327092 |
| 76 | regulation of tolerance induction (GO:0002643) | 3.22716913 |
| 77 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.21577980 |
| 78 | natural killer cell mediated immunity (GO:0002228) | 3.21577980 |
| 79 | response to muramyl dipeptide (GO:0032495) | 3.21314034 |
| 80 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.20297937 |
| 81 | lymphocyte costimulation (GO:0031294) | 3.20110635 |
| 82 | germinal center formation (GO:0002467) | 3.17075640 |
| 83 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.16409618 |
| 84 | B cell receptor signaling pathway (GO:0050853) | 3.15629394 |
| 85 | mature B cell differentiation (GO:0002335) | 3.15238002 |
| 86 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.15185712 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.13849707 |
| 88 | positive regulation of B cell mediated immunity (GO:0002714) | 3.13320345 |
| 89 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.13320345 |
| 90 | T-helper cell differentiation (GO:0042093) | 3.10068931 |
| 91 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.10068931 |
| 92 | regulation of hypersensitivity (GO:0002883) | 3.09266520 |
| 93 | positive regulation of T cell cytokine production (GO:0002726) | 3.07576709 |
| 94 | alpha-beta T cell activation (GO:0046631) | 3.07236841 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.06354158 |
| 96 | response to host immune response (GO:0052572) | 3.06354158 |
| 97 | negative regulation of T cell mediated immunity (GO:0002710) | 3.06247212 |
| 98 | positive regulation of tolerance induction (GO:0002645) | 3.06020688 |
| 99 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.05726138 |
| 100 | natural killer cell activation (GO:0030101) | 3.05252127 |
| 101 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.04663580 |
| 102 | myeloid cell activation involved in immune response (GO:0002275) | 3.03502772 |
| 103 | detection of biotic stimulus (GO:0009595) | 3.00941024 |
| 104 | * positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.00268474 |
| 105 | immunoglobulin mediated immune response (GO:0016064) | 2.97208086 |
| 106 | T cell homeostasis (GO:0043029) | 2.96810688 |
| 107 | regulation of antigen processing and presentation (GO:0002577) | 2.96731275 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.95169239 |
| 109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.95169239 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.95038396 |
| 111 | response to host (GO:0075136) | 2.95038396 |
| 112 | response to host defenses (GO:0052200) | 2.95038396 |
| 113 | * regulation of response to interferon-gamma (GO:0060330) | 2.94274728 |
| 114 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.93323663 |
| 115 | respiratory burst (GO:0045730) | 2.93304960 |
| 116 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.93199042 |
| 117 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.91591124 |
| 118 | regulation of necroptotic process (GO:0060544) | 2.91433358 |
| 119 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91065343 |
| 120 | T cell proliferation (GO:0042098) | 2.91024838 |
| 121 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.90960019 |
| 122 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.90960019 |
| 123 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.90638888 |
| 124 | cellular response to interferon-gamma (GO:0071346) | 2.90602119 |
| 125 | leukocyte cell-cell adhesion (GO:0007159) | 2.90073045 |
| 126 | neutrophil activation (GO:0042119) | 2.88773747 |
| 127 | defense response to protozoan (GO:0042832) | 2.88741260 |
| 128 | detection of molecule of bacterial origin (GO:0032490) | 2.88507203 |
| 129 | positive regulation of DNA recombination (GO:0045911) | 2.87393925 |
| 130 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86875741 |
| 131 | natural killer cell differentiation (GO:0001779) | 2.85338013 |
| 132 | T cell differentiation involved in immune response (GO:0002292) | 2.82997629 |
| 133 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.82997629 |
| 134 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.82997629 |
| 135 | response to protozoan (GO:0001562) | 2.82569880 |
| 136 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81699209 |
| 137 | microglial cell activation (GO:0001774) | 2.81164890 |
| 138 | B cell homeostasis (GO:0001782) | 2.80141340 |
| 139 | B cell mediated immunity (GO:0019724) | 2.77997091 |
| 140 | lymphocyte homeostasis (GO:0002260) | 2.74479716 |
| 141 | granulocyte activation (GO:0036230) | 2.72085667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.51597422 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.24351758 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.85198301 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.71471729 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.65061247 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.37771211 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.52748109 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.16069988 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13985179 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.06638519 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.93164460 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83809169 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.81761381 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.78776340 |
| 15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.75102254 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73971611 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.69134886 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68774010 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.60486564 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.59635301 |
| 21 | MYB_26560356_Chip-Seq_TH1_Human | 2.43813595 |
| 22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.36992615 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.34449707 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.24520006 |
| 25 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11677511 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.03788400 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.96768488 |
| 28 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.91249274 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89120817 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.88375229 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87615629 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85345015 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85120921 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.81679434 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81268834 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79661034 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77584601 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77098509 |
| 39 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76495280 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74694732 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70954605 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70464775 |
| 43 | * MAF_26560356_Chip-Seq_TH2_Human | 1.67803931 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64854807 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.53205135 |
| 46 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.52408497 |
| 47 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47079599 |
| 48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46863075 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46174337 |
| 50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43531618 |
| 51 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.43337962 |
| 52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.40331674 |
| 53 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39438273 |
| 54 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33415784 |
| 55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31151711 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29802841 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.28001965 |
| 58 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27457230 |
| 59 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26498417 |
| 60 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23266140 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23176076 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.20535855 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19361290 |
| 64 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18427931 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18035453 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11370612 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11052736 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10536690 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.10312815 |
| 70 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07241259 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06831541 |
| 72 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01870978 |
| 73 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00946363 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98674852 |
| 75 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98264939 |
| 76 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96798527 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96394326 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93702158 |
| 79 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92879521 |
| 80 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.92730464 |
| 81 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.92439041 |
| 82 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91701353 |
| 83 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90631134 |
| 84 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.88716515 |
| 85 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88510946 |
| 86 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87313198 |
| 87 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87301981 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.86910695 |
| 89 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85711546 |
| 90 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85051322 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.84490672 |
| 92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83456070 |
| 93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82572236 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.82069072 |
| 95 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81537004 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80989112 |
| 97 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.80573947 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80390500 |
| 99 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.78857403 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77770431 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77393800 |
| 102 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.76378413 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76196968 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.76020982 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.74395480 |
| 106 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.73815455 |
| 107 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73062603 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72718122 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72393275 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.69626495 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.66368082 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.65749092 |
| 113 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.64995190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.35933316 |
| 2 | MP0000685_abnormal_immune_system | 3.77570677 |
| 3 | MP0005671_abnormal_response_to | 3.54519796 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.33745909 |
| 5 | MP0005387_immune_system_phenotype | 3.26231439 |
| 6 | MP0001790_abnormal_immune_system | 3.26231439 |
| 7 | MP0001800_abnormal_humoral_immune | 3.21243644 |
| 8 | MP0002166_altered_tumor_susceptibility | 3.14697686 |
| 9 | MP0009785_altered_susceptibility_to | 3.02048972 |
| 10 | MP0003436_decreased_susceptibility_to | 2.98340148 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.89915569 |
| 12 | MP0002723_abnormal_immune_serum | 2.73976660 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.71085948 |
| 14 | MP0002006_tumorigenesis | 2.63682780 |
| 15 | MP0005025_abnormal_response_to | 2.63342928 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.57182094 |
| 17 | MP0001819_abnormal_immune_cell | 2.56804344 |
| 18 | MP0004510_myositis | 2.52536962 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.42262352 |
| 20 | MP0004947_skin_inflammation | 2.36509394 |
| 21 | MP0002398_abnormal_bone_marrow | 2.31393258 |
| 22 | MP0006082_CNS_inflammation | 2.28055590 |
| 23 | MP0002419_abnormal_innate_immunity | 2.26407181 |
| 24 | MP0001873_stomach_inflammation | 2.26362718 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 2.21569371 |
| 26 | MP0000716_abnormal_immune_system | 2.14319932 |
| 27 | MP0002254_reproductive_system_inflammat | 2.08718068 |
| 28 | MP0003303_peritoneal_inflammation | 2.04140859 |
| 29 | MP0002405_respiratory_system_inflammati | 2.01812037 |
| 30 | MP0003724_increased_susceptibility_to | 1.97179488 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.96914162 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.93445712 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.89707314 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.87506505 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.85364292 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.82529564 |
| 37 | MP0002722_abnormal_immune_system | 1.81086703 |
| 38 | MP0001853_heart_inflammation | 1.77117157 |
| 39 | MP0002429_abnormal_blood_cell | 1.74060256 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.70369777 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.68484253 |
| 42 | MP0008260_abnormal_autophagy | 1.64598509 |
| 43 | MP0002009_preneoplasia | 1.58494900 |
| 44 | MP0000569_abnormal_digit_pigmentation | 1.54445111 |
| 45 | MP0005310_abnormal_salivary_gland | 1.53078424 |
| 46 | MP0004808_abnormal_hematopoietic_stem | 1.48884716 |
| 47 | MP0005451_abnormal_body_composition | 1.44085259 |
| 48 | MP0008469_abnormal_protein_level | 1.42778284 |
| 49 | MP0003448_altered_tumor_morphology | 1.39030591 |
| 50 | MP0003866_abnormal_defecation | 1.38196658 |
| 51 | MP0001533_abnormal_skeleton_physiology | 1.34491151 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.33739998 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.33739998 |
| 54 | MP0003828_pulmonary_edema | 1.27208128 |
| 55 | MP0009278_abnormal_bone_marrow | 1.23469572 |
| 56 | MP0000858_altered_metastatic_potential | 1.21609205 |
| 57 | MP0009764_decreased_sensitivity_to | 1.15791115 |
| 58 | MP0002933_joint_inflammation | 1.15258253 |
| 59 | MP0002132_abnormal_respiratory_system | 1.15251366 |
| 60 | MP0004381_abnormal_hair_follicle | 1.12629078 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.12504397 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.09877474 |
| 63 | MP0004883_abnormal_blood_vessel | 1.09838083 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.09171711 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.06662269 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.01780687 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.96386354 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.96169849 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.94542099 |
| 70 | MP0001348_abnormal_lacrimal_gland | 0.93756084 |
| 71 | MP0001663_abnormal_digestive_system | 0.92677055 |
| 72 | MP0009763_increased_sensitivity_to | 0.91956710 |
| 73 | MP0000604_amyloidosis | 0.91918933 |
| 74 | MP0010307_abnormal_tumor_latency | 0.87407384 |
| 75 | MP0001851_eye_inflammation | 0.86555669 |
| 76 | MP0009840_abnormal_foam_cell | 0.86105107 |
| 77 | MP0005166_decreased_susceptibility_to | 0.85892748 |
| 78 | MP0005164_abnormal_response_to | 0.83620012 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.82836361 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 0.82430844 |
| 81 | MP0003690_abnormal_glial_cell | 0.82344786 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.81130090 |
| 83 | MP0005076_abnormal_cell_differentiation | 0.80962381 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.80949708 |
| 85 | MP0003091_abnormal_cell_migration | 0.79645568 |
| 86 | MP0000609_abnormal_liver_physiology | 0.79396058 |
| 87 | MP0003045_fibrosis | 0.77849515 |
| 88 | MP0005390_skeleton_phenotype | 0.76626703 |
| 89 | MP0000490_abnormal_crypts_of | 0.75723416 |
| 90 | MP0001216_abnormal_epidermal_layer | 0.73583277 |
| 91 | MP0008004_abnormal_stomach_pH | 0.72587271 |
| 92 | MP0003566_abnormal_cell_adhesion | 0.72238905 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.69403076 |
| 94 | MP0003075_altered_response_to | 0.69294703 |
| 95 | MP0005023_abnormal_wound_healing | 0.68707804 |
| 96 | MP0010234_abnormal_vibrissa_follicle | 0.68693980 |
| 97 | MP0000371_diluted_coat_color | 0.67785518 |
| 98 | MP0002136_abnormal_kidney_physiology | 0.67736101 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.66025816 |
| 100 | MP0004130_abnormal_muscle_cell | 0.65604993 |
| 101 | MP0003795_abnormal_bone_structure | 0.63470364 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.63036240 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.62837872 |
| 104 | MP0001191_abnormal_skin_condition | 0.60875183 |
| 105 | MP0008057_abnormal_DNA_replication | 0.58664463 |
| 106 | MP0001243_abnormal_dermal_layer | 0.58117568 |
| 107 | MP0008874_decreased_physiological_sensi | 0.57321059 |
| 108 | MP0002163_abnormal_gland_morphology | 0.55927467 |
| 109 | MP0000249_abnormal_blood_vessel | 0.55497717 |
| 110 | MP0009115_abnormal_fat_cell | 0.53629246 |
| 111 | MP0005381_digestive/alimentary_phenotyp | 0.52761891 |
| 112 | MP0001881_abnormal_mammary_gland | 0.52452897 |
| 113 | MP0000367_abnormal_coat/_hair | 0.51789780 |
| 114 | MP0003279_aneurysm | 0.51735080 |
| 115 | MP0000343_altered_response_to | 0.51150584 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.51094569 |
| 117 | MP0002796_impaired_skin_barrier | 0.50966157 |
| 118 | MP0000598_abnormal_liver_morphology | 0.50413285 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.50053119 |
| 120 | MP0009931_abnormal_skin_appearance | 0.49859088 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.49683070 |
| 122 | MP0000015_abnormal_ear_pigmentation | 0.49117320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.48605713 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.90076893 |
| 3 | Recurrent viral infections (HP:0004429) | 4.81961216 |
| 4 | Nasal polyposis (HP:0100582) | 4.80444963 |
| 5 | Abnormality of T cell number (HP:0011839) | 4.63651382 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.61547698 |
| 7 | T lymphocytopenia (HP:0005403) | 4.55610283 |
| 8 | Eczematoid dermatitis (HP:0000976) | 4.48940204 |
| 9 | Recurrent bronchitis (HP:0002837) | 4.44360463 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 4.25629944 |
| 11 | Recurrent abscess formation (HP:0002722) | 4.20545529 |
| 12 | Abnormality of the nasal mucosa (HP:0000433) | 4.19215461 |
| 13 | Myositis (HP:0100614) | 4.14865283 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.13406558 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.03547190 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.93874507 |
| 17 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.93874507 |
| 18 | Increased IgE level (HP:0003212) | 3.82751078 |
| 19 | Abnormality of the fingertips (HP:0001211) | 3.70249856 |
| 20 | Abnormality of T cells (HP:0002843) | 3.68617351 |
| 21 | Vasculitis (HP:0002633) | 3.63003846 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.61720679 |
| 23 | Pustule (HP:0200039) | 3.54078531 |
| 24 | Panhypogammaglobulinemia (HP:0003139) | 3.48299826 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.45796162 |
| 26 | Recurrent skin infections (HP:0001581) | 3.44456067 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.37126616 |
| 28 | Optic neuritis (HP:0100653) | 3.37126616 |
| 29 | Stomatitis (HP:0010280) | 3.36240588 |
| 30 | Orchitis (HP:0100796) | 3.33838966 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.28170101 |
| 32 | Colitis (HP:0002583) | 3.27933819 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.17461824 |
| 34 | Meningitis (HP:0001287) | 3.11832082 |
| 35 | Eosinophilia (HP:0001880) | 3.08046948 |
| 36 | Chronic sinusitis (HP:0011109) | 3.05569579 |
| 37 | Autoimmune hemolytic anemia (HP:0001890) | 3.05233705 |
| 38 | Increased IgM level (HP:0003496) | 3.03933622 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.03731916 |
| 40 | IgM deficiency (HP:0002850) | 3.03212326 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 3.02104030 |
| 42 | Periodontitis (HP:0000704) | 3.02084097 |
| 43 | Gastrointestinal infarctions (HP:0005244) | 2.99613648 |
| 44 | Thrombocytosis (HP:0001894) | 2.99464343 |
| 45 | Gingival bleeding (HP:0000225) | 2.98562317 |
| 46 | Arterial thrombosis (HP:0004420) | 2.96133876 |
| 47 | Leukocytosis (HP:0001974) | 2.95761071 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.95548110 |
| 49 | Spontaneous hematomas (HP:0007420) | 2.89641046 |
| 50 | Joint swelling (HP:0001386) | 2.87880376 |
| 51 | Granulocytopenia (HP:0001913) | 2.80688711 |
| 52 | Abnormality of eosinophils (HP:0001879) | 2.80610777 |
| 53 | IgG deficiency (HP:0004315) | 2.79772268 |
| 54 | Lymphopenia (HP:0001888) | 2.78454325 |
| 55 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.77150632 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.75161312 |
| 57 | Abnormality of macrophages (HP:0004311) | 2.75104422 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.73770667 |
| 59 | Hemoptysis (HP:0002105) | 2.73718922 |
| 60 | Chronic diarrhea (HP:0002028) | 2.72005530 |
| 61 | Cellulitis (HP:0100658) | 2.70814231 |
| 62 | Combined immunodeficiency (HP:0005387) | 2.69191038 |
| 63 | Myocardial infarction (HP:0001658) | 2.65440598 |
| 64 | Urticaria (HP:0001025) | 2.63902795 |
| 65 | Encephalitis (HP:0002383) | 2.60685477 |
| 66 | Emphysema (HP:0002097) | 2.58673786 |
| 67 | Papilloma (HP:0012740) | 2.57974536 |
| 68 | Verrucae (HP:0200043) | 2.57974536 |
| 69 | IgA deficiency (HP:0002720) | 2.52645468 |
| 70 | Epistaxis (HP:0000421) | 2.51703349 |
| 71 | Papilledema (HP:0001085) | 2.51433118 |
| 72 | Gingivitis (HP:0000230) | 2.50424094 |
| 73 | Interstitial pulmonary disease (HP:0006530) | 2.45989810 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.45097811 |
| 75 | Bronchitis (HP:0012387) | 2.43972977 |
| 76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42807830 |
| 77 | Obstructive lung disease (HP:0006536) | 2.42807830 |
| 78 | Thyroiditis (HP:0100646) | 2.42748269 |
| 79 | Hypochromic anemia (HP:0001931) | 2.40930552 |
| 80 | Chest pain (HP:0100749) | 2.40609703 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 2.39615240 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.37067469 |
| 83 | Fatigue (HP:0012378) | 2.33371300 |
| 84 | Hematochezia (HP:0002573) | 2.32319459 |
| 85 | Skin ulcer (HP:0200042) | 2.30506244 |
| 86 | Keratoconjunctivitis (HP:0001096) | 2.30043439 |
| 87 | Viral hepatitis (HP:0006562) | 2.29050425 |
| 88 | Anorexia (HP:0002039) | 2.27170184 |
| 89 | Abnormality of B cell number (HP:0010975) | 2.24867323 |
| 90 | B lymphocytopenia (HP:0010976) | 2.24867323 |
| 91 | Prolonged bleeding time (HP:0003010) | 2.24613768 |
| 92 | Slow saccadic eye movements (HP:0000514) | 2.24205534 |
| 93 | Abnormality of the pleura (HP:0002103) | 2.17836749 |
| 94 | Recurrent sinusitis (HP:0011108) | 2.16989157 |
| 95 | Sepsis (HP:0100806) | 2.14962745 |
| 96 | Pulmonary embolism (HP:0002204) | 2.13422157 |
| 97 | Abnormality of the prostate (HP:0008775) | 2.11826076 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.08093277 |
| 99 | Restrictive lung disease (HP:0002091) | 2.05681438 |
| 100 | Osteomyelitis (HP:0002754) | 2.04548823 |
| 101 | Thick nail (HP:0001805) | 2.04104888 |
| 102 | Lymphoma (HP:0002665) | 2.02928154 |
| 103 | Osteolytic defects of the hand bones (HP:0009699) | 2.01944759 |
| 104 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.01944759 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.01081008 |
| 106 | Gangrene (HP:0100758) | 2.00202357 |
| 107 | Abnormal platelet volume (HP:0011876) | 1.98986723 |
| 108 | Cheilitis (HP:0100825) | 1.98044674 |
| 109 | Episodic fever (HP:0001954) | 1.97754682 |
| 110 | Petechiae (HP:0000967) | 1.94093200 |
| 111 | Glomerulopathy (HP:0100820) | 1.93482990 |
| 112 | Peritonitis (HP:0002586) | 1.91982515 |
| 113 | Amaurosis fugax (HP:0100576) | 1.91869476 |
| 114 | Malnutrition (HP:0004395) | 1.90955794 |
| 115 | Arthralgia (HP:0002829) | 1.88971756 |
| 116 | Acute hepatic failure (HP:0006554) | 1.88457832 |
| 117 | Microcytic anemia (HP:0001935) | 1.87197687 |
| 118 | Premature loss of primary teeth (HP:0006323) | 1.86716281 |
| 119 | Abnormality of the peritoneum (HP:0002585) | 1.85804181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.35025430 |
| 2 | MAP3K14 | 4.02425354 |
| 3 | TYK2 | 4.02097891 |
| 4 | JAK3 | 3.68856036 |
| 5 | FGFR4 | 3.32788332 |
| 6 | IKBKE | 3.26749214 |
| 7 | PRPF4B | 3.23286045 |
| 8 | TXK | 3.13770312 |
| 9 | JAK1 | 2.93382165 |
| 10 | MAP3K13 | 2.87330641 |
| 11 | TBK1 | 2.67928448 |
| 12 | KIT | 2.24247893 |
| 13 | FGFR3 | 2.21164591 |
| 14 | IKBKB | 2.18004707 |
| 15 | ITK | 2.12966080 |
| 16 | ZAP70 | 1.98899478 |
| 17 | MAP3K10 | 1.83731654 |
| 18 | IRAK4 | 1.79821473 |
| 19 | STK10 | 1.79211697 |
| 20 | CHUK | 1.64473224 |
| 21 | GRK6 | 1.63646778 |
| 22 | BLK | 1.61610121 |
| 23 | LCK | 1.56069948 |
| 24 | SYK | 1.49468691 |
| 25 | EPHB1 | 1.45515146 |
| 26 | BTK | 1.41898758 |
| 27 | CSK | 1.40713352 |
| 28 | IRAK3 | 1.35877475 |
| 29 | HCK | 1.34268549 |
| 30 | TEC | 1.33722143 |
| 31 | NLK | 1.31466476 |
| 32 | CSF1R | 1.29378742 |
| 33 | SIK2 | 1.28922031 |
| 34 | ERN1 | 1.28561386 |
| 35 | EEF2K | 1.27582039 |
| 36 | EPHA3 | 1.26731542 |
| 37 | CDC42BPA | 1.21486117 |
| 38 | FLT3 | 1.19306867 |
| 39 | RIPK4 | 1.18035882 |
| 40 | JAK2 | 1.16414928 |
| 41 | TAOK1 | 1.13557269 |
| 42 | PIM1 | 1.09291725 |
| 43 | CDK12 | 1.05590480 |
| 44 | LRRK2 | 1.03490116 |
| 45 | MARK2 | 1.02007955 |
| 46 | MAP3K1 | 0.96822645 |
| 47 | PRKCQ | 0.93678598 |
| 48 | RPS6KA4 | 0.93064227 |
| 49 | SMG1 | 0.92984010 |
| 50 | PKN2 | 0.91596131 |
| 51 | MARK3 | 0.91146837 |
| 52 | MAP3K11 | 0.87294214 |
| 53 | TAOK3 | 0.87198943 |
| 54 | MST4 | 0.86923029 |
| 55 | MAPK7 | 0.84374183 |
| 56 | BMPR2 | 0.83288439 |
| 57 | TRIB3 | 0.81657794 |
| 58 | TGFBR2 | 0.80957176 |
| 59 | TTN | 0.79498196 |
| 60 | MAPK12 | 0.77377709 |
| 61 | PRKD2 | 0.77169285 |
| 62 | NEK9 | 0.76065483 |
| 63 | LYN | 0.75359839 |
| 64 | PTK6 | 0.74143241 |
| 65 | CAMKK1 | 0.71251065 |
| 66 | FES | 0.70768722 |
| 67 | NME2 | 0.70572641 |
| 68 | IRAK1 | 0.70407292 |
| 69 | MAP3K7 | 0.70070701 |
| 70 | CAMKK2 | 0.69980283 |
| 71 | YES1 | 0.69460472 |
| 72 | MAP2K3 | 0.66561370 |
| 73 | TAOK2 | 0.65244336 |
| 74 | STK4 | 0.64399148 |
| 75 | SIK1 | 0.63320673 |
| 76 | SIK3 | 0.62036588 |
| 77 | KSR2 | 0.61120987 |
| 78 | PRKAA2 | 0.57189448 |
| 79 | MAPK11 | 0.57003415 |
| 80 | PDPK1 | 0.56773426 |
| 81 | PASK | 0.55926703 |
| 82 | PRKCH | 0.54607904 |
| 83 | CDK4 | 0.53082200 |
| 84 | PIM2 | 0.52935792 |
| 85 | FYN | 0.52560591 |
| 86 | TRPM7 | 0.51193258 |
| 87 | CLK1 | 0.50854247 |
| 88 | PIK3CG | 0.50646183 |
| 89 | HIPK2 | 0.49351120 |
| 90 | MATK | 0.48732390 |
| 91 | KDR | 0.47269901 |
| 92 | MAP3K6 | 0.46965561 |
| 93 | CDK6 | 0.46307203 |
| 94 | TGFBR1 | 0.44655652 |
| 95 | PKN1 | 0.43388332 |
| 96 | GRK7 | 0.42600620 |
| 97 | RPS6KA5 | 0.42381590 |
| 98 | PDGFRB | 0.41642078 |
| 99 | STK38 | 0.40975777 |
| 100 | RPS6KL1 | 0.40520747 |
| 101 | RPS6KC1 | 0.40520747 |
| 102 | EGFR | 0.39660864 |
| 103 | IRAK2 | 0.39101890 |
| 104 | PTK2B | 0.37459706 |
| 105 | ABL1 | 0.37427499 |
| 106 | MAP2K6 | 0.37125824 |
| 107 | TYRO3 | 0.36145694 |
| 108 | STK11 | 0.35852962 |
| 109 | PDK1 | 0.35437342 |
| 110 | SGK2 | 0.35377004 |
| 111 | MAPKAPK2 | 0.34624754 |
| 112 | CAMK1D | 0.34566198 |
| 113 | MAP3K3 | 0.33359051 |
| 114 | RIPK1 | 0.31657145 |
| 115 | TNK2 | 0.30164627 |
| 116 | BMX | 0.29155351 |
| 117 | RET | 0.28886690 |
| 118 | CDK9 | 0.26903360 |
| 119 | FGFR2 | 0.26051902 |
| 120 | RPS6KA6 | 0.26001231 |
| 121 | IGF1R | 0.25515873 |
| 122 | SGK3 | 0.25194062 |
| 123 | MAPK4 | 0.25042371 |
| 124 | PRKCD | 0.24802402 |
| 125 | MELK | 0.24510687 |
| 126 | ALK | 0.24121482 |
| 127 | MAPK3 | 0.23453951 |
| 128 | INSR | 0.23377231 |
| 129 | NEK2 | 0.23029270 |
| 130 | DYRK1B | 0.22815687 |
| 131 | EIF2AK2 | 0.22468443 |
| 132 | FGR | 0.22461373 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.80725595 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.26402393 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.93028035 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.87031286 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84970655 |
| 6 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71142479 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.61261782 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45382677 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.44389744 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.39626969 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.34097932 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.28710835 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27202490 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15579885 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.14128731 |
| 16 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.10194536 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.02876339 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.99643179 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.96646496 |
| 20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.88399310 |
| 21 | Influenza A_Homo sapiens_hsa05164 | 1.87853261 |
| 22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.82017699 |
| 23 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.81963736 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.77590798 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70758992 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.59084008 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.57903926 |
| 28 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47599549 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.44247452 |
| 30 | Hepatitis B_Homo sapiens_hsa05161 | 1.38025024 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37150718 |
| 32 | Hepatitis C_Homo sapiens_hsa05160 | 1.35610618 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32957437 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.31498766 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.31422876 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.29727159 |
| 37 | Pertussis_Homo sapiens_hsa05133 | 1.25880382 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.23644759 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.20115981 |
| 40 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17972281 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.13065157 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05840106 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05484956 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03423405 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.02747350 |
| 46 | Asthma_Homo sapiens_hsa05310 | 1.02345661 |
| 47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.01898780 |
| 48 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95703386 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95199776 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94642828 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91412874 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90576992 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84648577 |
| 54 | HTLV-I infection_Homo sapiens_hsa05166 | 0.84055502 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.82020837 |
| 56 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81798193 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 0.81047660 |
| 58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78359256 |
| 59 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.77606147 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.73059537 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.72520967 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67968245 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67690901 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65024477 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.64492612 |
| 66 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62567470 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60783287 |
| 68 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.60699721 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58746022 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58671064 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57107567 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55114566 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51314524 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.45223906 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43840504 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42059800 |
| 77 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41159763 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41120738 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40960455 |
| 80 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39885457 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39544530 |
| 82 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.39415232 |
| 83 | Lysine degradation_Homo sapiens_hsa00310 | 0.39225872 |
| 84 | Glioma_Homo sapiens_hsa05214 | 0.35373357 |
| 85 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35300476 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.32003423 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.31918763 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31745906 |
| 89 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31647725 |
| 90 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30120042 |
| 91 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29762220 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29345659 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.28795324 |
| 94 | Prostate cancer_Homo sapiens_hsa05215 | 0.28596677 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28547019 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.28437719 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.28081266 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.27398857 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26864324 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25185407 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24000668 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.22962557 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22739314 |
| 104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21595925 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19588722 |
| 106 | Other glycan degradation_Homo sapiens_hsa00511 | 0.19536823 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.17618384 |
| 108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16468338 |
| 109 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.14101339 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.13045961 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.12179000 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.11616406 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10296137 |

